NUVL
Nuvalent Inc
NASDAQ: NUVL · HEALTHCARE · BIOTECHNOLOGY
$99.10
-2.79% today
Updated 2026-04-29
Market cap
$8.01B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.85
Dividend yield
—
52W range
$64 – $113
Volume
0.6M
Nuvalent Inc (NUVL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $3.32M | $10.65M | $293.82M | $482.46M | $732.38M | $1.14B |
| Cash & equivalents | — | — | — | — | — | — |
| Current assets | $3.32M | $10.65M | $290.63M | $477.99M | $726.49M | $1.13B |
| Total liabilities | $20.57M | $41.97M | $8.79M | $19.48M | $31.82M | $71.96M |
| Current liabilities | $4.35M | $4.38M | $8.79M | $19.48M | $31.82M | $54.02M |
| Long-term debt | $2.17M | $2.23M | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — |
| Retained earnings | $-17.33M | $-31.89M | $-78.22M | $-160.08M | $-286.30M | $-547.05M |
| Accounts receivable | — | — | $3.20M | $4.47M | — | — |
| Inventory | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |